Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Secunderabad Healthcare Ltd Stock Analysis

Small Cap
Evaluated by 61 users | BSE: 524540 | NSE: |
Hospital & Healthcare Services

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on Capital Employed 64.2%42.76%-1.09%2.91%0.31%0.31%-0.04%-0.02%0.07%0.07%-0.09%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 8.419.915.918.457.522.614.37.56.23.10.50
Y-o-Y Gr. Rt.-137.5%-20.1%15.7%211.9%-60.6%-36.9%-47.6%-17.8%-49%-83.8%-
Adjusted EPS (Rs.) 4.946.67-0.230.610.050.06-0.0100.010.01-0.02-0.05
Y-o-Y Gr. Rt.-35%-103.5%NA-91.8%20%-116.7%NANA0%-300%-
Book Value per Share (Rs.) 10.1614.914.6615.2818.7518.7418.7418.7518.7618.7818.7618.75
Adjusted Net Profit 1.82.4-0.10.20.20.5-0.100.10.1-0.20
Net Op. Cash Flow (Rs. Cr.) 0.74.4-0.101.721.10.100.60-
Debt to Cash Flow from Ops 00004.882031.64177.14678.3529.010-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Secunderabad Healthcare Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -33.5%-53.2%-59.2%-83.8%
Adjusted EPS -152.4%-180.3%NA-300%
Book Value per Share 2.600-0.1
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on Equity (%) 64.1842.66-1.112.90.330.36-0.06-0.020.070.07-0.1-0.27
Operating Profit Margin (%) 23.5913.247.35.411.733.622.382.075.8512.937.36142.35
Net Profit Margin (%) 20.9411.91-0.521.190.352.18-0.61-0.51.913.49-30.89-161.08
Debt to Equity 00000.10.250.220.120.10.10.030.02
Working Capital Days 864763882371,3242,6555,3705,4668,37255,585-
Cash Conversion Cycle 111243612644591172324225,125-
Loading price chart...
Entity Percentage Holding
Promoters 0.03%
Non-Institutions 99.97%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Data is not available for this company.

Secunderabad Healthcare was incorporated on October 31, 1991 and went public on April 4, 1994. The company is based in Hyderabad, India.

The company engages in the medical services business in India. It focuses on sourcing and procuring medicines and nutraceuticals for pharmacies. The business model has been changed from health diagnostics and healthcare to pharmaceuticals, biotechnology and nutraceuticals. Good quality products are sourced from USA and offered at competitive rates to

Secunderabad Healthcare was incorporated on October 31, 1991 and went public on April 4, 1994. The company is based in Hyderabad, India.

The company engages in the medical services business in India. It focuses on sourcing and procuring medicines and nutraceuticals for pharmacies. The business model has been changed from health diagnostics and healthcare to pharmaceuticals, biotechnology and nutraceuticals. Good quality products are sourced from USA and offered at competitive rates to Indian pharmacies.

The company plans to source and procure medicines and nutraceuticals for new generation pharmacies in India.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback